Thank you for your interest. Give here your contact details and you'll receive an email with the pdf file you request.
Sign up to our monthly newsletter to receive our news.
A new advance in the understanding of breast cancer and a new pharmacological approach
The team of Pierre Close and Alain Chariot (GIGA-Molecular Biology of Diseases) from the University of Liège has identified a genetic way to block breast cancer.
Breast cancer is the most prevalent cancer in women. It would affect 1 woman on 9.
It is known that any tumor grows from genetic mutations and from changes in the cellular environment, at the level of protein expression. The step of protein production is a crucial mechanism in tumor cells adaptation and metastasis formation.
The researchers have demonstrated that the expression of ELP3 and CTU1/2 enzymes, involved in the regulation of protein synthesis, is up-regulated in human breast cancers.
In addition, they have shown that ELP3 genetic ablation strongly impaired the tumor growth in the mammary gland and its metastatic progression. Moreover, the inhibition of these enzymes significantly reduces the invasion of breast cancer cells.
A molecular dissection allowed to highlight that the various steps leading to metastasis development cannot be implemented without ELP3 and CTU1/2. Indeed, these enzymes are crucial for translating the oncogenic DEK protein that regulates the expression of LEF1 transcription factor.
The expression levels of ELP3, DEK and LEF1 are actually correlated in human mammary tumors and are associated with an increased risk of developing metastases. Therefore, the results obtained by the team of GIGA, illustrate the crucial role of this enzymatic cascade in the regulation of protein translation, in tumoral development and in metastatic progression in breast cancer.
The inhibition of these enzymes could be a new pharmacological approach for the treatment of metastatic breast tumors.
These results have been published in the “Journal of Experimental Medicine”
In collaboration with a team at the University of California at Los Angeles (UCLA), researchers from GIGA-Neurosciences have discovered a new gene responsible for a seizure syndrome called juvenile myoclonic epilepsy (JME). This discovery was made as part of an international consortium that studies genetic abnormalities responsible for epileptic diseases. It is being published this week in
The LIGHTSHEET MICROSCOPY can deliver optical sections, 3D reconstructions and timelapse movies of whole sample volumes at subcellular resolutions. The fast scan speeds and low phototoxicity of the lightsheet allow to record the development of fluorescent transgenic animals over long time periods, such as zebrafish embryos. Alternatively 3D reconstructions of fixed whole organs or whole embryos,
The researchers discovered that this cellular dialogue controls the growth of the cerebral cortex and that its impairment leads a cortical malformation previously associated with autism in mice . Their results are published in the prestigious scientific journal Cell. The cerebral cortex contains excitatory and inhibitory interneurons. The former are produced locally and move by